fbpx

As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community. Innovation represents one of the strongest pillars of the company with more than 50 in-house scientists and a unique network of talented and renowned medical doctors contributing to Regen LabÔÇÖs Research & Development.

Over nearly 15 years, this innovation has been secured by building substantial patent & trademarks portfolios. Intellectual Property Rights (IPRs) therefore represent core assets of the company protecting its unique products and forging Regen LabÔÇÖs renowned brand names.

The patent portfolio can be divided into two core technologies:

1-PRP/BMC gel devices, methods and uses thereof, alone or in combination with cell extracts and associated key technologies like Autologous Thrombin Serum (ATS) and PRP Cell Culture.

Associated trademarks are REGENLAB®, REGENKIT®, REGENACR®, PRP®, A-PRP®, REGENCELL®, REGENPLASMA®, REGEN PRP®, REGEN®, REGEN EXTRACELL®, THT®, cellularmask®, CUTECELL®, REGENVET®, A-CPKIT® which are registered trademarks of REGEN LAB SA in Europe, United States and other countries.

2-Hyaluronic acid alone, cross-linked or not, or in combination with PRP/BMC leading to the unique ÔÇťall in oneÔÇŁ Cellular Matrix products combining in a synergetic manner the advantageous properties of PRP and HA, but also preparation in two separate devices.

Associated trademarks are REGENLAB®, REGENKIT®, CELLULAR MATRIX® fig., SKINVISC®, ARTHROVISC®, REGENMATRIX®, REGEN®, PRP® and A-PRP® which are registered trademarks of REGEN LAB in Europe, United States and other countries.

 

Technology Products / Trademarks Patent(s) Status
A-PRPBone Marrow Concentrate (BMC)

Glue and membranes

Combination with Cell Extracts

Cell Culture

RegenACR®
RegenKit® Surgery
RegenKit® BCT
A-CP Kit®
Regen Fibrin Polymer
RegenKit® Extracell
RegenwoundÔäó
Regen Extracell®
Regencell®
Regenplasma®
THT®
Cutecell®
A-PRP®
REGENPRP®
REGEN®
PRP®
Regenvet®
US11241458
US11110128
US11096966
US10881691
US10092598
US10080770
US10064894
US8529957
US9833478
US11241458
US11389482
US10052349 (PRP+HA)
EP3395383B
CH696752
HK1231793
Granted
US2022313740
EP4137173
HK62023069504.6
WO2008/023026
WO2011/110948
WO2016/083549
WO2019/155391
Pending
Autologous Thrombin Serum (ATS) alone

Combination with A-PRP for biological glues and membranes

RegenKit® ATS
RegenwoundÔäó
Regenkit Wound
A-CP ATS Kit
US10226516
EP3403659B
AU2013203115B
JP6359495
JP6588499
CA2915649
IL252122
KR10-2136314
IN330984
HK1179507
Granted
WO2011/110948
CN105998067
CN202211204780.2
RU2023102455
Pending
Combination therapy

A-PRP & Hyaluronic   Acid

 

 

 

 

 

 

ellular Matrix® fig. (linear HA)

A-CP-HA
BCT-HA               RegenMatrix
(X-linked HA)

US10272139
US8945537
US9517255
US10052349
EP2544697B1
EP3184114B
EP2771241B
CA2789533C
JP6076091
JP6321119
JP6892485
AU2011225828B
IL221133
RU2614722
RU2667964
KR20130067247
IN330984
HK1179507
US11077241
EP3223875B
AU2015352458B
EA035982B
MA40376B
IL252536
MX382517
UA123822
KR102362722B1
BR112017010837
BH1857-20220915
Granted
WO2011/110948
WO2013/061309
WO2019/155391
US2019201504
US2018327120
CN112220802
EP3854406
HK42021040392.9
HK40050052
CA2968731
CL20170001357
CN20158073651
CR20170000288
JP20180135503
KR20170088366
PE20170931
PH2017150094
SG20171104218P
TN20170000220
US2018110917
AU2019218711
CA3089896
GCC2019/38117
EP3743079
JP2021515088
US2022193116
TW108128394
CN112118849
HK62020021959.5
KR10-2020-0130685
Pending
Cellular Matrix Wound IL284309
KR10-2521213
AU2021201102B2
Granted
EP3903844
HK42021044735.5
US2021346587
WO2022/269035
GB2219505.1
Pending
Viral infections (Covid 19) RegenARPÔäó WO2021/198312
CA3170584
AU2021249444
EP4114526
US 17/916,507
HK62023067606.1
Pending
N/A Granted
Albumin-based bioresorbable cross-linked hydrogel R&D EP1543846B1 Granted

V2023.2  May 22, 2023

 

about

Contact Regenlab

Now is the time to change your patient’s life. Browse ressources and
get connected to treatment that is right for them.

For more information on our products, please contact us by clicking on the button below:

picto

Our Regional offices are
located in

  • New York (USA)
  • Montr├ęal (Canada)
  • Venice (Italy)
  • Munich (Germany)
  • Paris (France)
  • Dubai (U.A.E.)
  • Beijing (China)
  • and Istanbul (Turkey)